'Deep Molecular Response' Boosts CML Survival (CME/CE)

(MedPage Today) -- A majority of patients with chronic myelogenous leukemia achieved a deep molecular response with imatinib-based therapy, which correlated with improved long-term and progression-free survival, a randomized trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/12/molecular-response-boosts-cml-survival.html